This is the pickaxe’ of drug discoveries, Gus Scacco says

Key Concepts

• Dow Jones Industrials: A stock market index representing 30 large, publicly owned companies based in the United States.
• Multiple Myeloma: A type of cancer that forms in a type of white blood cell called a plasma cell.
• Thermo Fisher Scientific: A company providing scientific instrumentation, reagents and consumables, and software services.
• AI (Artificial Intelligence): The simulation of human intelligence processes by machines, especially computer systems.
• Drug Discovery: The process by which new candidate medications are discovered.
• Guidance (Financial): A company's forecast of its future financial performance.
• Bull Market: A period when stock prices are generally rising.
• Earnings Growth: The increase in a company's profits over a specific period.
• Margin Improvement: An increase in a company's profit margin, indicating greater efficiency or pricing power.
• Data Centers: Facilities used to house computer systems and associated components, such as telecommunications and storage systems.

Market Performance and Economic Indicators

The Dow Jones Industrials is on the verge of a significant milestone, potentially achieving its first close above 48,000. This follows a strong performance with a 355-point jump, building on a previous 559-point gain. This upward momentum suggests a sustained bull market, with expectations for continued growth. One analyst has been anticipating a market downturn for the past four years, but it has not materialized.

Government and Regulatory News

The House of Representatives is set to begin tackling a vote that could potentially lead to the reopening of the government. In other news, the FDA has granted approval to Thermo Fisher Scientific for its new Extent system, designed to aid doctors in identifying multiple myeloma.

Investment Spotlight: Thermo Fisher Scientific

AI Connection and Growth Potential

Thermo Fisher Scientific is highlighted as a company benefiting from the advancements in Artificial Intelligence (AI). The company's work in mapping proteins is described as a foundational element for new drug discovery, akin to a "pickaxe" for identifying starting points for new treatments. This is expected to drive significant drug discovery over the next 3-5 years.

Stock Performance and Outlook

Thermo Fisher's stock has performed exceptionally well, up 21% quarter-to-date. The outlook suggests a further ramp-up in performance, with expectations for continued growth in the coming year. This optimism is supported by strong earnings growth, with 13% growth in the past quarter exceeding expectations of 7.5%. This growth is attributed to margin improvement from productivity gains and accelerating revenue.

The AI Debate and Applications

AI Bubble Concerns

While there is an ongoing debate about a potential AI bubble, companies deeply involved in the sector, such as those in biotechnology, are seeing billions of dollars invested. The speaker believes the real potential for AI lies in its application to biotechnology.

Broader AI Applications

The application of AI is expanding beyond biotechnology into other areas. For instance, eBay is mentioned as a company benefiting from AI, which is making quick throughs (likely referring to customer service or sales processes) easier. AI is also helping to overcome language barriers that previously impacted sales.

Guidance and Expectations

Despite the positive outlook for AI adoption, eBay lowered its guidance for the holiday quarter. This was a proactive measure, as the company had previously beaten expectations in the last quarter. The CEO has been a strong proponent of implementing AI within the company.

Market Outlook and Sustainability

Sustained Bull Market

The continued strong performance of the Dow Jones Industrials, particularly the potential close above 48,000, indicates a robust bull market. The market has shown resilience, defying expectations of a downturn.

Earnings and Revenue Growth

Earnings growth for the past quarter was 13%, significantly higher than the expected 7.5%, with expectations for acceleration next year. This is driven by margin improvements from productivity gains and a resurgence in revenue.

AI as an Energy Generator and Potential Pauses

AI is viewed as a significant "generator of energy" for the market, similar to the impact of the internet. However, the analogy of race cars needing to refuel suggests that there might be periods of pause or consolidation. The speaker does not foresee this in the short term, citing the ongoing build-out of data centers as a key indicator of continued demand. The transcript mentions that data center build-out is at "1% o" which is an incomplete statistic but implies a very early stage or low percentage of completion.